Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform
NCT: NCT07333547 · RECRUITING
Brief Summary
The WILLEM Registry is a large-scale, single-group, observational, registry study to collect continuous clinical evidence of Willem in real-world settings. Cardiovascular diseases are a major problem for public health and healthcare systems. Electrocardiograms (ECGs) are simple tests which increase diagnostic performance and early detection of cardiovascular diseases. However, its interpretation is complex, time consuming for cardiology experts, and entails high costs for healthcare systems. Willem allows AI-based automatic interpretation and its performance has been examined in previous clinical trials, but additional clinical evidence is needed for its integration in real-world clinical settings. This study will collect clinical evidence of Willem performance to detect cardiac abnormalities in ECGs from high-risk cardiac patients admitted to cardiovascular units.
Frequently Asked Questions
What is Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform?
Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform is a clinical trial registered under NCT07333547. Current status: RECRUITING.
What is the status of NCT07333547?
The current status of NCT07333547 (Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform) is: RECRUITING.
When did Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform start?
Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform started on 2026-02-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.